live

Coronavirus Updates: Kolkata Police Commissioner Anuj Sharma tests positive for COVID-19, says report

Coronavirus Updates: Lok Sabha Speaker Om Birla on Thursday also said that 62 percent of the Parliament's operations have been 'successfully' moved online will go '100 percent digital eventually'

FP Staff September 12, 2020 08:21:55 IST
Auto refresh feeds
Coronavirus Updates: Kolkata Police Commissioner Anuj Sharma tests positive for COVID-19, says report

Highlights

LIVE NEWS and UPDATES

Sept 10, 2020 - 21:09 (IST)

Coronavirus in Maharashtra Latest Updates

23,446 new COVID-19 cases in Maharashtra today

The Maharashtra government said that 23,446 new cases and 448 deaths were reported in the state on Thursday. Additionally,14,253 patients were discharged.

The total cases in the state rise to 9,90,795, including 28,282 deaths and 7,00,715 patients discharged. Active cases 2,61,432.

Sept 10, 2020 - 20:18 (IST)

Coronavirus in Delhi Latest Updates

4,308 new COVID-19 cases in Delhi today

The Delhi government said that 4,308 new COVID-19 cases and 28 deaths, and 2,637 recoveries were reported in the last 24 hours. The total cases in the national capital rise to 2,05,482 including 4,666 deaths and 1,75,400 recovered/discharged/migrated. Active cases are 25,416.

"9,004 RTPCR/CBNAAT/True Nat tests and 49,336 Rapid antigen test conducted today. A total of 19,62,120 tests done so far," the statement added.

Sept 10, 2020 - 19:38 (IST)

Coronavirus in China Latest Updates

China approves first nasal spray COVID-19 vaccine for trials

 

China has approved for trials its first nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media here reported on Thursday.

China's only nasal spray vaccine against the coronavirus is expected to start phase I clinical trials in November, and it is recruiting 100 volunteers.

It is the only vaccine of its type approved by China's National Medical Products Administration, the state-run Global Times reported.

The vaccine is a collaborative mission between Hong Kong and the Chinese mainland that involves researchers from the University of Hong Kong, Xiamen University, and Beijing Wantai Biological Pharmacy.

Sept 10, 2020 - 19:05 (IST)

Coronavirus in Kerala Latest Updates

3,349 new COVID-19 cases in Kerala

The Kerala government said that 3,349 new COVID-19 cases were reported on Thursday. Active cases now at 26,229; also 72,578 patients have recovered so far in the state.

Sept 10, 2020 - 18:54 (IST)

Coronavirus in West Bengal Latest Updates

Kolkata Metro to run trains on 13 Sept for NEET students

Kolkata Metro on Thursday said that it will resume operations on 14 September from 8 am. A total of 110 trains will run at an interval of 10 minutes. Only Smart card passengers allowed to travel.

Additionally, the statement said that the Metro will also operate on 13 September only for NEET aspirants and their parents.

Sept 10, 2020 - 18:12 (IST)

Coronavirus Pandemic Latest Updates

AstraZeneca says COVID-19 vaccine still possible this year: Report

AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials, ANI reported.

"Earlier this week, the UK-Swedish company reportedly froze the trials after discovering that one participant was sick with transverse myelitis," the report said.

Sept 10, 2020 - 18:07 (IST)

Coronavirus in Karnataka Latest Updates

BS Yediyurappa instructs officials to bring down COVID-19 death rate

Cautioning about high number of COVID-19 cases being reported from the state, Karnataka chief minister BS Yediyurappa on Thursday asked the district administrations to work towards bringing down the death rate.

He said providing immediate treatment to those with COVID-19 symptoms and saving the lives of those infected is his government's priority. Yediyurappa also instructed officials to see to it that there are no issues or complaints regarding relief to those affected by the recent floods triggered by heavy rains in the state.

Sept 10, 2020 - 17:31 (IST)

Coronavirus in Delhi Latest Updates

Delhi govt to continue using plasma therapy in COVID-19 treatment, says report

News18 reported that the Delhi government will continue to include plasma therapy in the treatment for COVID-19 patients, despite the ICMR data not proving that the method is beneficial for patients.

The report quoted Delhi’s health minister Satyendar Jain as saying so on Thursday "despite clinical trials not proving whether plasma therapy can help people fighting the infection."

Sept 10, 2020 - 17:00 (IST)

Coronavirus in India Latest Updates

257 MPs to sit in Lok Sabha main hall, 172 in gallery

Lok Sabha Speaker was quoted by The Times of India as saying that the seating arrangement has been decided thus: "257 members will sit in the Lok Sabha main hall and 172 will be seated in the visitors’ gallery. Remaining 81 members will seated in Rajya Sabha Hall," the report said.

Sept 10, 2020 - 16:47 (IST)

Coronavirus in India Latest Updates

Om Birla says seats allocated to parties in both Houses

Lok Sabha Speaker Om Birla on Thursday said, "Seats have been allocated to different parties proportionally in the two Houses of the Parliament as per their respective strengths. Members above 60-65 years have been advised to sit in galleries."

His statement comes as MPs are gearing up for the Parliament's Monsoon Session, which is set to begin on 14 September, amid the COVID-19 pandemic.

Coronavirus LATEST Updates: Lok Sabha Speaker Om Birla on Thursday said that the Parliament will go "100 percent digital eventually", in the run up to the Monsoon Session set to begin on 14 September.

"For the first time in the history of Parliament, all members have sent their questions through online medium. We have successfully made 62% of our operations digital," he added.

He said, "All members will undergo COVID-19 testing. Attendance of parliamentarians will be recorded through a mobile app. Session will commence from 14 September. It's challenging for us amid pandemic but we've to prove ourselves to people to whom we are accountable."

The Serum Institute of India, which has partnered with Oxford University and AstraZeneca in the development of a coronavirus vaccine, said that it has paused trials of the vaccine in India a day after its UK counterparts announced that they were also stopping trials.

Serum Institute of India said, "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and will not be able to comment further on trials."

The development came after a volunteer in the human trials of the vaccine in the UK developed an "unexplained illness", reports said.

Mamata Banerjee on Thursday said that the proposed lockdown on 12 September will be cancelled, in view of NEET 2020 examination scheduled on Sunday.

India's COVID-19 mortality rate has dropped to 1.68 percent while the recovery rate is at 77.74 percent.

India's COVID-19 tally had crossed 20 lakh on 7 August, it went past 30 lakh on 23 August and 40 lakh on 5 September.

With the death of more than 1,100 COVID-19 patients in the past 24 hours, the toll increased from 73,890 to 75,063 on Thursday, according to latest data released by the Ministry of Health and Family Welfare.

The global COVID-19 toll from the coronavirus passed 900,000 on Wednesday, as worldwide cases crossed 27.7 million.

The United States remained the world's worst-affected country, with deaths exceeding 190,000 and cases exceeding 6.3 million. Brazil is in second place with more than 127,000 deaths followed by India with nearly 74,000 dead.

Wednesday saw India's coronavirus cases cases cross 43 lakh with 89,706 infections being reported between Tuesday and 8 am Wednesday. Durign these 24 hours, the country's recovery rate also inched up to 77.77 percent with 33,98,844 recoveries. However, the search for a vaccine to stem the spread of the virus suffered a setback as trial for the Oxford vaccine candidate by pharma giant AstraZeneca was paused after a UK participant had an adverse reaction to it.

The central drug regulator DCGI has issued a show-cause notice to Serum Institute of India (SII), which had received a go-ahead to conduct phase 2 and phase 3 trials for the same vaccine candidate in India.

Trial for one of COVID-19 vaccine candidates hits a roadblock 

The Drugs Controller General of India, Dr V G Somani, in his show-cause notice has asked SII as to why the permission granted for conducting phase 2 and 3 clinical trials of the Oxford vaccine candidate in the country be not suspended till patient safety is established.

"Whereas, Serum Institute of India Pvt Ltd, Pune, till now has not informed the Central licensing authority regarding pausing the clinical trial carried out by AstraZeneca in other countries and also not submitted casualty analysis of the reported serious adverse event with the investigational vaccine for the continuation of phase 2 and 3 clinical trials of the subject vaccine in the country in light of the safety concerns," said the show-cause notice accessed by PTI.

The drug regulator also mentioned that the clinical trials have been put on hold across countries where it is conducted, ie, USA, UK, Brazil and South Africa.

Earlier, SII, which has partnered with the British-Swedish company AstraZeneca for manufacturing the Oxford vaccine candidate for COVID-19, had said it was going to continue with the trials in India even after reports came that AstraZeneca has suspended the trial.

"We can''t comment much on the UK trials, but they have been paused for further review and they hope to restart soon," SII said, adding that the country has faced no issues at all with India trials so it is going to go ahead with them.

Delhi reports record new cases; five states account for 62% active cases

The National Capital recorded 4,039 fresh COVID-19 cases on Wednesday, the highest single-day spike so far, as the tally breached the two lakh-mark, while the toll from the virus mounted to 4,638, authorities said.

This is the first time since the outbreak of the pandemic that over 4,000 cases have been recorded in Delhi in a day.

The previous highest single-day spike of 3,947 cases was recorded on 23 June. Twenty fatalities have been recorded in the last 24 hours, according to the latest bulletin issued by the Delhi health department. The tally of active cases rose to 23,773 from 22,377 the previous day, it said.

The death toll from COVID-19 in Delhi stood at 4,618 on Tuesday.

The news assumes significance in the wake of the fact that Delhi has been reopening in a phased manner with the metro services resuming partially merely two days ago. A report from Wednesday morning said that over 33,000 people travelled in a single day.

Meanwhile, Chief Minister Arvind Kejriwal ruled out the possibility of another lockdown, stating that the economy of the national capital cannot stay shut till eternity. Dehli education minister Satyendra Jain also said that the COVID-19 pandemic-induced uncertainties has led to a "drastic" drop in the average spend of people, indicating that the immediate focus was on reviving the economy while also trying to curb the spread of the disease.

As for the rest of India, according to the health ministry, Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu account for 62 percent of total active coronavirus cases in the country.

Like Delhi, Maharashtra too reported its single-day highest spike of 23,816 new cases taking the total count to 9,67,349. Andhra's total tally reached 5,27,512 with 10,418 new cases while Karnataka recorded a spike of 7,866 cases. Uttar Pradesh reported 6,711 new cases in 24 hours while Tamil Nadu 5,584 cases, taking the tally to 4,80,524.

Of the total 73,890 COVID-19 deaths in India, Maharashtra has reported the maximum at 27,407 followed by 8,012 in Tamil Nadu, 6,680 in Karnataka, 4,618 in Delhi,4,560 in Andhra Pradesh, 4,047 in Uttar Pradesh, 3,677 in West Bengal, 3,133 in Gujarat and 1,990 in Punjab.

So far, 1,609 people have died of COVID-19 in Madhya Pradesh, 1,164 in Rajasthan, 916 in Telangana, 854 in Haryana, 815 in Jammu and Kashmir, 765 in Bihar, 569 in Odisha, 496 in Jharkhand, 407 in Chhattisgarh, 378 in Assam,  372 in Kerala and 360 in Uttarakhand.

With inputs from PTI

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

‘Significant movement' on Phase-3 trial, manufacture of Russia's Sputnik V vaccine, says NITI Aayog
India

‘Significant movement' on Phase-3 trial, manufacture of Russia's Sputnik V vaccine, says NITI Aayog

Dr VK Paul, who chairs the national expert group on COVID-19 vaccine administration, said that the government of India attaches 'great importance to this offer of partnership from a friend'

India reports over 90,000 COVID-19 cases in a single day, toll rises to 70,626
India

India reports over 90,000 COVID-19 cases in a single day, toll rises to 70,626

According to the latest health ministry data, the COVID-19 case fatality rate has further declined to 1.72 percent

Coronavirus Vaccine Tracker: Serum Institute of India pauses clinical trials after DCGI show-cause notice
Health

Coronavirus Vaccine Tracker: Serum Institute of India pauses clinical trials after DCGI show-cause notice

The Pune-based company said that it's reviewing the situation and pausing India trials of the COVID-19 vaccine candidate till AstraZeneca restarts the trials